Impact of Telehealth Education in Diabetes Patients
Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2
About this trial
This is an interventional other trial for Diabetes Mellitus, Type 1 focused on measuring self care
Eligibility Criteria
Inclusion Criteria: patients who were hospitalized at Hospital Israelita Albert Einstein and included in the subcutaneous insulin protocol to control hyperglycemia patients monitored by the Diabetes Program, an institutional program that manages glycemic changes that occur within the institution. patients with type 1 or type 2 Diabetes Mellitus or those with an HbA1C level greater than or equal to 6.5% during hospitalization. Exclusion Criteria: Patients not submitted to the first face-to-face educational approach required by protocol Patients discharged on the weekend or holidays
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Active Comparator
Experimental
Standard education
Amplied education
Standard education group will be carried out at discharge, discharge orientation of the patient with diabetes and application of the Diabetes Self-Care Activity Questionnaire (QAD). For this group, a new contact will be made within 30 days after discharge, where the QAD will be applied again.
Amplied education group will be performed at the time of discharge, guidance for discharge of patients with diabetes. This group will receive 3 contacts, the first will be carried out within 72 hours after discharge, the second contact within 10 days after the first contact and the third within 30 days after discharge, where diabetes education guidelines will be given to the patient in all contacts. At the time of discharge, and in the third contact, 30 days, the QAD will also be applied.